BR112017014849A2 - Processo para preparação de ácido hialurônico- butirato e uso de um ácido hialurônico-butirato - Google Patents

Processo para preparação de ácido hialurônico- butirato e uso de um ácido hialurônico-butirato

Info

Publication number
BR112017014849A2
BR112017014849A2 BR112017014849A BR112017014849A BR112017014849A2 BR 112017014849 A2 BR112017014849 A2 BR 112017014849A2 BR 112017014849 A BR112017014849 A BR 112017014849A BR 112017014849 A BR112017014849 A BR 112017014849A BR 112017014849 A2 BR112017014849 A2 BR 112017014849A2
Authority
BR
Brazil
Prior art keywords
hyaluronic acid
butyrate
preparation
sodium
relates
Prior art date
Application number
BR112017014849A
Other languages
English (en)
Other versions
BR112017014849B1 (pt
Inventor
Sechi Alessandra
Stucchi Luca
Gianni Rita
Original Assignee
Sigea Srl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sigea Srl filed Critical Sigea Srl
Publication of BR112017014849A2 publication Critical patent/BR112017014849A2/pt
Publication of BR112017014849B1 publication Critical patent/BR112017014849B1/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/728—Hyaluronic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73—Polysaccharides
    • A61K8/735—Mucopolysaccharides, e.g. hyaluronic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14—Macromolecular materials
    • A61L27/20—Polysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/04—Macromolecular materials
    • A61L31/042—Polysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
    • C08B37/0063—Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
    • C08B37/0072—Hyaluronic acid, i.e. HA or hyaluronan; Derivatives thereof, e.g. crosslinked hyaluronic acid (hylan) or hyaluronates
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L5/00—Compositions of polysaccharides or of their derivatives not provided for in groups C08L1/00 or C08L3/00
    • C08L5/08—Chitin; Chondroitin sulfate; Hyaluronic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2430/00—Materials or treatment for tissue regeneration
    • A61L2430/34—Materials or treatment for tissue regeneration for soft tissue reconstruction

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Polymers & Plastics (AREA)
  • Engineering & Computer Science (AREA)
  • Materials Engineering (AREA)
  • Biochemistry (AREA)
  • Birds (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Surgery (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Transplantation (AREA)
  • Vascular Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Inorganic Chemistry (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Cosmetics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

a presente invenção se refere a um processo para preparação de ácido hialurônico-butirato ou um sal deste, aceitável para uso farmacêutico ou cosmético ou como dispositivo médico, compreendendo a reação do ácido hialurônico, salificado com sódio ou outro metal alcalino, em solução aquosa com butirilimidazolida na presença de carbonato de sódio. a presente invenção também se refere a formulações farmacêuticas, formulações cosméticas ou dispositivos médicos que contêm os ésteres butíricos do sal sódico do ácido hialurônico (ha) produzidos por tal processo.
BR112017014849-8A 2015-01-13 2016-01-08 Processo para preparação de ácido hialurônico-butirato e uso de um ácido hialurônico- butirato BR112017014849B1 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
ITMI2015A000017 2015-01-13
ITMI20150017 2015-01-13
PCT/EP2016/050268 WO2016113192A1 (en) 2015-01-13 2016-01-08 Process in water for the preparation of butyric esters of hyaluronic acid sodium salt

Publications (2)

Publication Number Publication Date
BR112017014849A2 true BR112017014849A2 (pt) 2018-01-09
BR112017014849B1 BR112017014849B1 (pt) 2022-05-17

Family

ID=52574320

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112017014849-8A BR112017014849B1 (pt) 2015-01-13 2016-01-08 Processo para preparação de ácido hialurônico-butirato e uso de um ácido hialurônico- butirato

Country Status (14)

Country Link
US (1) US10618982B2 (pt)
EP (1) EP3245233B1 (pt)
JP (1) JP6738337B2 (pt)
KR (1) KR102636528B1 (pt)
CN (1) CN107106694B (pt)
BR (1) BR112017014849B1 (pt)
CA (1) CA2973416C (pt)
DK (1) DK3245233T3 (pt)
ES (1) ES2704290T3 (pt)
PL (1) PL3245233T3 (pt)
PT (1) PT3245233T (pt)
RU (1) RU2708994C2 (pt)
WO (1) WO2016113192A1 (pt)
ZA (1) ZA201704637B (pt)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT201900021693A1 (it) 2019-11-20 2021-05-20 Bmg Pharma S P A Derivati butirrati o butirrati e formiati dell’acido ialuronico reticolati e loro procedimento di reticolazione
IT202000001831A1 (it) * 2020-01-30 2021-07-30 Caprika Srl Composizione per applicazione rettale a base di sale di acido butirrico per il trattamento delle patologie proctologiche

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE171185T1 (de) * 1985-03-15 1998-10-15 Antivirals Inc Immunotestmittel für polynukleotid und verfahren
EP0416250A3 (en) * 1989-08-01 1991-08-28 The Research Foundation Of State University Of New York N-acylurea and o-acylisourea derivatives of hyaluronic acid
US5616568A (en) * 1993-11-30 1997-04-01 The Research Foundation Of State University Of New York Functionalized derivatives of hyaluronic acid
JP3563440B2 (ja) * 1994-05-16 2004-09-08 生化学工業株式会社 アシル化ヒアルロン酸の製造法
IT1286510B1 (it) * 1996-11-29 1998-07-15 Cooperativa Centro Ricerche Po Esteri butirrici ad attivita' antiproliferativa e composizioni farmaceutiche che li contengono
ITMI20022745A1 (it) * 2002-12-23 2004-06-24 Coimex Scrl United Companies Esteri misti dell'acido ialuronico ad attivita' citostatica e prodifferenziante e procedimento per la loro produzione.
ITMI20030043A1 (it) * 2003-01-14 2004-07-15 Coimex S C R L United Companies Uso di esteri retinoici dell'acido ialuronico in cellule
US7091191B2 (en) * 2003-12-19 2006-08-15 Ethicon, Inc. Modified hyaluronic acid for use in musculoskeletal tissue repair
ITMI20040605A1 (it) * 2004-03-29 2004-06-29 Coimex S C R L United Companie Esteri butirrici dell'acido ialuronico a basso grado di sostituzione procedimento per la loro preparazione ed uso
FR2908415B1 (fr) * 2006-11-10 2009-01-23 Abr Dev Sarl Acide hyaluronique reticule et son procede de preparation
EP1942117A1 (en) * 2006-12-29 2008-07-09 Sigea S.R.L. Derivatives of acid polysaccharides
ITMI20072237A1 (it) * 2007-11-27 2009-05-28 Sigea Srl Esteri misti butirrico-formico di polisaccaridi acidi, loro preparazione ed uso come dermocosmetici
US20090143348A1 (en) * 2007-11-30 2009-06-04 Ahmet Tezel Polysaccharide gel compositions and methods for sustained delivery of drugs
WO2012048283A1 (en) * 2010-10-08 2012-04-12 Board Of Regents, The University Of Texas System One-step processing of hydrogels for mechanically robust and chemically desired features
ITGE20120102A1 (it) * 2012-10-25 2014-04-26 Lipogems Internat S R L Procedimento di precondizionamento chimico di materiale cellulare per ottenere la riprogrammazione epigenetica chimica e l'espressione di pluripotenzialità

Also Published As

Publication number Publication date
PT3245233T (pt) 2019-01-16
KR20170105010A (ko) 2017-09-18
ZA201704637B (en) 2018-12-19
EP3245233A1 (en) 2017-11-22
CN107106694A (zh) 2017-08-29
CA2973416A1 (en) 2016-07-21
RU2017124364A (ru) 2019-02-14
RU2017124364A3 (pt) 2019-07-17
ES2704290T3 (es) 2019-03-15
JP6738337B2 (ja) 2020-08-12
RU2708994C2 (ru) 2019-12-12
US20180273648A1 (en) 2018-09-27
PL3245233T3 (pl) 2019-06-28
WO2016113192A1 (en) 2016-07-21
DK3245233T3 (en) 2019-01-28
US10618982B2 (en) 2020-04-14
JP2018501385A (ja) 2018-01-18
CN107106694B (zh) 2020-09-22
KR102636528B1 (ko) 2024-02-15
BR112017014849B1 (pt) 2022-05-17
EP3245233B1 (en) 2018-10-24
CA2973416C (en) 2023-05-09

Similar Documents

Publication Publication Date Title
BR112017027831A2 (pt) derivados de hidroxiácido, um processo para sua preparação e composições farmacêuticas contendo-os
CL2015003346A1 (es) Composiciones de cenicriviroc y métodos para realizarlas y utilizarlas
BR112017002811A2 (pt) compostos de pirrolopirimidina usados como agonista de tlr7
BR112016017261A8 (pt) composto, composição farmacêutica, uso de um composto e processo para a fabricação de um composto
MY170302A (en) Process for the preparation of an aqueous solution comprising at least one earth alkali hydrogen carbonate and its use
BR112014025711A8 (pt) composto, medicamento, e, uso de um composto
BR112017007123A2 (pt) derivados de tetrahidroisoquinolina
JO3241B1 (ar) عملية لتحضير محلول مائي يتألف على الاقل من كربونات هيدروجين الكيل خبأ واستخدامه
BR112015020772A2 (pt) compostos de pirimidina e piridina e seu uso
BR112015000520A2 (pt) agente de espessamento estável com lipase
BR112013028449A2 (pt) composições compreendendo partículas de hidrogel
BR112015021332A2 (pt) sal de sódio de ácido (2s, 5r)-6-benzilóxi-7-oxo-1,6-diaza-biciclo [3.2.1] octano-2-carboxílico e sua preparação
BR112015029088A2 (pt) sistema de múltiplas bateladas para preparar uma solução de hidrogeno carbonato de cálcio, e, uso de uma solução de hidrogeno carbonato de cálcio
AR082776A1 (es) Estabilizacion de hormona foliculo estimulante (fsh)
CL2015003738A1 (es) Formulación líquida estable de amg-416 (velcalcetida)
BR112012028308A2 (pt) formulações oftálmicas de galactomanano estabilizadas
BR112017004231A2 (pt) processo para produzir um precipitado estável enriquecido em ficobiliproteínas
BR112015014176A2 (pt) associação de uma imagem de nuvem de pontos com um desenho de linhas de tubulação e aplicação de dimensões relativas à mesma
BR112014027582A8 (pt) composições oftalmicas com proteção e retenção de dessecação aperfeiçoada
BR112015030431A2 (pt) formulação de liberação modificada
WO2013168965A3 (ko) 포도상구균 감염 예방용 백신 조성물
BR112017001803A2 (pt) aril-hidrazidas contendo uma fração de 2-piridona como agentes antibacterianos seletivos
BR112017014849A2 (pt) Processo para preparação de ácido hialurônico- butirato e uso de um ácido hialurônico-butirato
BR112014027885A2 (pt) produção de ingredientes farmacêuticos ativos estéreis
BR112018008588A2 (pt) composição, e, processo para preparar uma composição.

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]

Free format text: DE ACORDO COM O ARTIGO 229-C DA LEI NO 10196/2001, QUE MODIFICOU A LEI NO 9279/96, A CONCESSAO DA PATENTE ESTA CONDICIONADA A ANUENCIA PREVIA DA ANVISA. CONSIDERANDO A APROVACAO DOS TERMOS DO PARECER NO 337/PGF/EA/2010, BEM COMO A PORTARIA INTERMINISTERIAL NO 1065 DE 24/05/2012, ENCAMINHA-SE O PRESENTE PEDIDO PARA AS PROVIDENCIAS CABIVEIS.

B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]
B06U Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette]
B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 08/01/2016, OBSERVADAS AS CONDICOES LEGAIS